KRISHGEN BioSystems Drug discovery > Pre-Clinical Development Products & Reviews

The Daratumumab (Darzalex) ELISA kit is an assay intended for the quantitative determination of Daratumumab (Darzalex) in serum, plasma and cell culture samples.

The Palivizumab ELISA kit is intended for the quantitative determination of Palivizumab in serum, plasma and cell culture samples.

The Pembrolizumab ELISA kit is intended for the quantitative determination of Pembrolizumab in serum, plasma and cell culture samples. RUO only.

ELISA for the quantitative determination of Insulin Glargine in serum and plasma samples.

ELISA for the quantitative determination of Insulin Aspart in serum and plasma samples.

ELISA for the quantitative determination of Exenatide in human serum and plasma.

ELISA for the quantitative determination of Liraglutide (VICTOZA™) in serum and plasma.

ELISA for the quantitative determination of Semaglutide in serum and plasma.

ELISA for the quantitative determination of Leuprolide / Leuprorelin in serum and plasma.

Immunoassay for quantitative estimation of Glatiramer Acetate in human serum and plasma. Validated for both serum and plasma samples, this Exenatide ELISA gives specific, accurate results with a ready-to-use assay format.

ELISA for Quantitative Determination of Serratia endonuclease in Cell Culture and Biological Samples.

The Rituximab ELISA kit is intended for the quantitative determination of Rituximab in serum, plasma and cell culture samples. Validated against International NIBSC standards by WHO.

Enzyme Immunoassay for the quantitative determination of Dasatinib in serum, plasma and cell culture supernatant.

The Nivolumab ELISA kit is an assay intended for the quantitative determination of Nivolumab in serum, plasma and cell culture samples.

Enzyme Immunoassay for the quantitative determination of Anti-Atezolizumab antibodies in serum and plasma.

The Infliximab ELISA kit is intended for the quantitative determination of Infliximab in serum, plasma and cell culture samples. Validated against NIBSC international standards from WHO.

Enzyme Immunoassay for the quantitative determination of Anti-Natalizumab antibodies in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Sacituzumab Govitecan in human serum and plasma.

Immunoassay for the measurement of Bovine Serum Albumin in cell culture samples.

Immunoassay for the measurement of Protein A in samples containing Human immunoglobulin.

The Desmpressin ELISA kit is intended for the quantitative determination of Desmopressin in serum and plasma samples.

Enzyme Immunoassay for the quantitative determination of Anti-Adalimumab antibodies in human serum and plasma.

Enzyme Immunoassay for the Qualitative / Quantitative Screening of double stranded RNA in mRNA based preparations.

Immunoassay for the measurement of E.coli Host Cell Proteins

ELISA for the detection of Blinatumomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year